Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 176

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease

Mastrogiacomo, Frank, Bergeron, Catherine, Kish, Stephen J.·1993·Journal of Neurochemistry

Abstract

We measured the activity of the a‐ketoglutarate dehydrogenase complex (α‐KGDHC), a rate‐limiting Krebs cycle enzyme, in postmortem brain samples from 38 controls and 30 neuropathologically confirmed Alzheimer's disease (AD) cases, in both the presence and absence of thiamine pyrophosphate (TPP), the enzyme's cofactor. Statistically significant correlations between brain pH and lactate levels and α‐KGDHC activity in the controls were observed, suggesting an influence of agonal status on the activity of α‐KGDHC. As compared with the controls, mean α‐KGDHC activity, with added TPP, was significantly (p < 0.005) reduced in AD brain in frontal (‐56%), temporal (‐60%), and parietal (‐68%) cortices, with the reductions (‐25 to ‐53%) in the occipital cortex, hippocampus, amygdala, and caudate failing to reach statistical significance. In the absence of exogenously administered TPP, mean a‐KGDHC activity was reduced to a slightly greater extent in all seven AD brain areas (‐39 to ‐83%), with the reductions now reaching statistical significance in the four cerebral cortical areas and hippocampus. A statistically significant negative correlation was observed between α‐KGDHC activity and neurofibrillary tangle count in AD parietal cortex, the brain area exhibiting the most marked reduction in enzyme activity; this suggests that the enzyme activity reduction in AD brain may be related to the disease process and severity. In each brain area examined, TPP produced a greater stimulatory effect on α‐KGDHC activity in the AD group (23–280% mean stimulation) as compared with the controls (‐4 to ±50%); this TPP effect could be explained by reduced endogenous TPP levels in AD brain. Reduced brain α‐KGDHC activity could be consequent to loss of neurons preferentially enriched in α‐KGDHC, a premortem reduction in TPP levels (which may have affected enzyme stability), elevated brain levels of the α‐KGDHC inhibitor ammonia, or an actual failure in the expression of the gene encoding the enzyme. We suggest that a defect in this key Krebs cycle enzyme could contribute to an impairment of cerebral energy metabolism and the brain dysfunction in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1993.tb07436.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 176

Metadata

Authors
Mastrogiacomo, F., Bergeron, C., & Kish, S. J.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
1993-12
Volume
61
Issue
6
Pages
2007-2014
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2060332652
Cited by
176
References
5
FWCI
4.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease. https://app.cochat.ai/papers/10.1111/j.1471-4159.1993.tb07436.x
The paper
Mastrogiacomo, F., Bergeron, C., & Kish, S. J. (1993). Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1993.tb07436.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.